KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Income from Non-Controlling Interests (2023 - 2025)

Edwards Lifesciences (EW) has 3 years of Income from Non-Controlling Interests data on record, last reported at -$800000.0 in Q3 2025.

  • For Q3 2025, Income from Non-Controlling Interests rose 42.86% year-over-year to -$800000.0; the TTM value through Dec 2025 reached -$4.1 million, changed N/A, while the annual FY2025 figure was -$4.1 million, N/A changed from the prior year.
  • Income from Non-Controlling Interests reached -$800000.0 in Q3 2025 per EW's latest filing, up from -$1.7 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at -$200000.0 in Q4 2023 and bottomed at -$1.7 million in Q2 2025.
  • Average Income from Non-Controlling Interests over 3 years is -$1.2 million, with a median of -$1.3 million recorded in 2024.
  • The widest YoY moves for Income from Non-Controlling Interests: up 42.86% in 2025, down 77.78% in 2025.
  • A 3-year view of Income from Non-Controlling Interests shows it stood at -$200000.0 in 2023, then crashed by 600.0% to -$1.4 million in 2024, then surged by 42.86% to -$800000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Non-Controlling Interests were -$800000.0 in Q3 2025, -$1.7 million in Q2 2025, and -$1.6 million in Q1 2025.